Genentech
Business Services · California, United States · 13,638 Employees
Who is Genentech
Genentech was founded in 1976. This company researches and manufactures pharmaceuticals for consumers with life-threatening medical conditions. Their headquarters are located in San Francisco, California.Read More
Headquarters:
1 Dna Way Mailstop 258A, South San Francisco, California, 94080, United States
Phone Number:
(650) 225-2500
Revenue:
$6 Billion
Genentech's Social Media
Popular Searches:
GENENTECH
Genentech Inc
Genentech , Inc.
Genentech Inc.
Genentech Access Solutions
Top Competitors of Genentech
Genentech's Org Chart
Phone
EmailGenentech Email Formats
Genentech uses at least 5 email formats with last.first (ex. Smith.John@gene.com) being used 71% of the time
Get Verified Emails
| Genentech Email Formats | Percentage | |
|---|---|---|
| last.first | Smith.John@gene.com | 71% |
| first.last | John.Smith@gene.com | |
| first + last | JohnSmith@gene.com | |
| first_last | John_Smith@gene.com | |
| first | John@gene.com | |
Genentech Company Metrics
Funding
| Funding Date | Round | Amount | Investors | |
|---|---|---|---|---|
Jun 30, 1976 | Unspecified | $100M | Kleiner Perkins Caufield & Byers |
See More
$100M
Total Funding Amount
$100M
Most Recent Funding Amount
1
Number of Funding Rounds
Revenue
| Quarter | Revenue |
|---|---|
'21 - Q1 | 6051874000 |
'21 - Q2 | 6051874000 |
Acquisitions & Subsidiaries
Oct 31, 2017
PVT Probenverteiltechnik
Jun 23, 2017
Tusk Therapeutics
Dec 06, 2016
Jecure Therapeutics
Sep 16, 2013
Seragon Pharmaceuticals
Jul 24, 2013
Genable Technologies
Jan 17, 2012
Ariosa Diagnostics
See More Acquisitions & Subsidiaries
Genentech's Tech Stack
Genentech News & Media
New Pivotal Data Demonstrate Clinical Benefit of Genentech’s Glofitamab, a Potential First-in-Class Bispecific Antibody for People With Aggressive Lymphoma
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new pivotal data on its investigational CD20xCD3 T-cell engaging bispecific antibody, glofitamab, will be presented for the first time at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting from June 3-7 and the European Hematology Association (EHA) 2022 Congress from June 9-12. Data from the Phase II NP30179 expansion study demonstrated that,
May 26, 2022
Data at the 2022 ASCO Annual Meeting Highlight Genentech’s Continued Commitment to Innovation in Oncology and Personalized Healthcare
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new data from clinical trials of 18 approved and investigational medicines across more than 20 cancer types will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held June 3-7, 2022. Genentech and its partners will present clinical studies across medicines, comprehensive genomic tests, and real-world data at thMay 24, 2022
Genentech Reports Interim Results for Phase III SKYSCRAPER-01 Study in PD-L1-High Metastatic Non-Small Cell Lung Cancer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from its Phase III SKYSCRAPER-01 study, evaluating the investigational anti-TIGIT immunotherapy tiragolumab plus Tecentriq® (atezolizumab) versus Tecentriq alone as an initial (first-line) treatment for people with PD-L1-high locally advanced or metastatic non-small cell lung cancer (NSCLC). The study did not meet its co-primary endpoint of progression-freeMay 11, 2022Subscribe to "Genentech" News
Frequently Asked Questions regarding Genentech
Where are Genentech’s headquarters?
Genentech’s headquarters are in 1 Dna Way Mailstop 258A, South San Francisco, California, 94080, United States
What is Genentech’s phone number?
Genentech’s phone number is (650) 225-2500
What is Genentech’s official website?
Genentech’s official website is www.gene.com
What is Genentech’s Revenue?
Genentech’s revenue is $6 Billion
What is Genentech’s SIC code?
Genentech’s SIC: 28,283
What is Genentech’s NAICS code?
Genentech’s NAICS: 541711,3254
How many employees are working in Genentech?
Genentech has 13,638 employees
What is Genentech’s industry?
Genentech is in the industry of: Business Services, Research & Development, Manufacturing
Who are Genentech’s main competitors?
Genentech's main competitors are: Biogen, Seattle Genetics, Amgen, CSL
What companies has Genentech acquired?
Genentech has acquired the companies: PVT Probenverteiltechnik, Tusk Therapeutics, Jecure Therapeutics, Seragon Pharmaceuticals
What is Genentech's tech stack?
The technologies that are used by Genentech are: Tenable, LabVIEW, Dataiku, Westlaw
Who is Genentech's CEO?
Genentech's CEO is Alexander Hardy
Who is Genentech's CFO?
Genentech's CFO is Ed Harrington
Rate Alexander Hardy as a Chief Executive Officer
User Ratings 
4.4/5 on G2 Crowd
Test Drive ZoomInfo's Directories
Browse Directories
